Inject in a single weekly injection, under the skin (subcutaneously)
According to data from the SURMOUNT clinical trial program, participants showed consistent weekly weight loss throughout the dose escalation period, with slight plateaus when adjusting to new doses
Reduces appetite and increases satiety to support sustainable weight management Enhances insulin sensitivity and reduces post-meal glucose spikes to help maintain healthy glucose levels Acts on brain pathways that control hunger and food intake Improved weight and metabolic control may help reduce risk factors associated with cardiometabolic disease Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in regulating appetite, insulin secretion, and blood sugar levels
If you are incorporating peptides for muscle growth or fat loss protocols alongside tirzepatide, strategic timing can reduce the likelihood that post-injection fatigue or nausea disrupts your training quality
Standard reconstitution steps 01 Inspect the vial Confirm label, vial size, and that the powder cake is intact
Nicely done